CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Galmed Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Galmed Pharmaceuticals Ltd
16 Tiomkin Street
Phone: +972 36938448p:+972 36938448 TEL AVIV-YAFO, 6578317  Israel Ticker: GLMDGLMD
Business Summary
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director AllenBaharaff 57
Chief Financial Officer DoronCohen 59 2/1/2022 2/1/2022
Chief Operating Officer, Data Protection Officer GuyNehemya 37 1/1/2021 3/1/2017
7 additional Officers and Directors records available in full report.

Business Names
Business Name
Galmed International Ltd.
Galmed Research and Development Ltd.
Galmed Therapeutics UK Limited
Galtopa Therapeutics Ltd.
GLMD
GPH

General Information
Number of Employees: 3 (As of 12/31/2023)
Outstanding Shares: 6,009,654 (As of 3/27/2024)
Shareholders: 1
Stock Exchange: NASD
Federal Tax Id: 981147233
Fax Number: +972 36938447


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024